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Introduction   
   
Sleep disordered breathing has been used to describe a spectrum conditions ranging 
from snoring as a mild form to Obstructive Sleep apnea which is a more severe form. 
Upper airway resistance syndrome falls in between the two. These disorders are 
commonly the result of conditions or diseases which cause partial or complete 
obstruction of airway when the patient is supine. 
   One of the first references of a patient with medical and physical characteristic 
features of sleep disordered breathing was made in a famous novel by Charles Dickens
 
known as the Pickwikian papers where he described a character named Sam.
1
 The 
condition was named as the Pickwikian syndrome. In 1956 Burwell referred Pickwick 
Papers and its obese character when describing the Pickwikian syndrome as consisting 
of obesity, hypersomnolence, hypoventilation, and cor pulmonale.
2
 In 1960 this 
disease was named as Obesity Hypoventilation syndrome. Over the years further 
research in this field have resulted in formation of a new medical specialty known as 
the “sleep medicine”.  
              There are several modalities of treatment for obstructive sleep apnea. The use 
of oral appliances for management of airway obstruction dates back to early 1900 
when the French stomatologist Pierre Robin used oral appliances to manage upper 
airway obstruction of neonates born with Pierre Robin syndrome.
3
 Since then Oral 
appliance therapy and therefore dentistry has become an important component of 
treating patients with upper airway sleep disorders. In 1995 the American Sleep 
Disorders Association published its parameters of Care document that recommends 
treatment modalities for Upper airway sleep disorders (UASD) where oral appliances 
are a treatment of choice for snoring and mild to moderate OSA in certain patients 
and ahead of surgical procedures for all but the most severe patients.
4
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Abstract      
                         
Sleep disordered breathing has been used to describe a spectrum conditions 
ranging from snoring as a mild form to Obstructive Sleep apnea (OSA) which is a 
more severe form. Upper airway resistance syndrome falls in between the two. 
Oral appliance therapy and therefore dentistry has become an important 
component of treating patients with upper airway sleep disorders. This article 
places oral appliances as a treatment of choice for snoring and mild to moderate 
Obstructive sleep Apnea in certain patients and ahead of surgical procedures for 
all but the most severe patients. 
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 Etiology 
     Obstuctive sleep apnea has complex etiology and 
consists of multifactorial interplay between the 
neuromuscular systems, airway and anatomical 
structures.
5
 The upper airway is basically a soft tissue 
tube, the patency of which is maintained in part by the 
activity of muscular groups of which the tensor veli and 
genioglossus muscles are highly important members. 
The action of these muscle groups has an important 
influence on the physiology of sleep disorders. The 
airway of a patient with snoring is obstructed due to 
tongue or hyoid bone and overlying soft tissues 
dropping back towards the posterior wall of pharynx 
when the patient is supine in order to get sufficient 
oxygen to the lungs. There is increase in velocity of air 
passing through narrow airway which in turn causes 
vibration of soft tissues especially the soft palate and 
uvula. This vibration is the sound of snoring.
6-9
 
Obstructive sleep apnea patients may suffer from 
hundreds of apneic events per night, which by definition 
are blockages of airway lasting more than 10 seconds.
10 
There are several factors which predispose to obstructive 
sleep apnea, the most important being obesity. Clinic 
based and epidemiological studies demonstrate a strong 
association between obesity and obstructive sleep 
apnea. Potential mechanisms to be considered include: 
(1) alterations in upper airway structure; (2) alterations in 
upper airway function; (3) alterations in the balance 
between ventilatory drive and load and (4) obesity 
induced hypoxemia.
11
 Other factors include head 
posture, inflammation of surrounding soft tissue, tonsils, 
adenoids
12-13
 or epiglottis, tumor, structural compromise, 
retrognathia 
14-17
, paralysis of intraoral muscles, nasal 
septal deviation, longer anterior facial height
18
 etc.  
 
Clinical characteristics 
 
 Overweight with a large neck
11
 
 Hypertensive 
19
 
 Does not get adequate amount of sleep 
 Dozes during the day 
 Accident prone 
 May awaken from sleep gasping for air 
 Suffers from reflux 
 Often is retrognathic
14
 
 
Diagnosis 
 
Diagnosis is based on medical history, physical 
examination and testing. Polysomnogram or sleep study 
is the gold standard. This study records sleep staging 
like electroencephalography (EEG), electrooculography 
(EOG), electromyography (EMG), and physiological 
variables like sleep positioning, respiratory activity, 
oxygen saturations, blood pressure and Ecocardiogram. 
Polysomnography reveals the quality and quantity of 
sleep. Polysomnogram (PSG) provides apnea index (AI), 
Hypoapnea index (HI) and Apnea-Hypoapnea index 
(AHI). Polysomnography reveals that OSA patients will 
characteristically fall asleep, experience an upper airway 
blockage, exhibit loud snoring, stop breathing, 
experience a drop in  blood oxygen  levels, attempts to 
breath, arouse, gasp for air, breathe for a few seconds 
blockage, exhibit loud snoring, stop breathing, 
experience a drop in  blood oxygen  levels, attempts to 
breathe, arouse, gasp for air, breathe for a few seconds 
and fall back asleep. Once the Sa02 (saturated oxygen) 
drops to a certain level, patients will have an arousal and 
begin breathing again.
19
  
 
Treatment modalities 
 
Non specific therapy  
 Behavior modification  include changing the sleep 
position from the supine position to the side position; 
this can be accomplished by placing a tennis ball in the 
centre of the back of their dress or by positioning a 
pillow such that they cannot roll on to their back 
(positional training). The avoidance of alcohol and 
sedatives; they may also act as muscle relaxants, 
reducing airway patency. In obese patients, weight loss 
should be recommended.
19
 Even a 10% weight loss can 
reduce the number of apneic events for most patients. 
 
Specific therapy 
 
1. Oxygen administration
20 
Oxygen is sometimes used in patients with central apnea 
caused by heart failure. Oxygen at the correct flow rate 
when used in conjunction with nasal continuous positive 
airway pressure (CPAP), however, in many cases corrects 
this problem. 
 
2. Pharmacological agent 
Thyroid hormone supplementation might lead to 
significant correction of the apnea if this is the sole 
problem. Control of blood sugar levels has a moderate 
effect in controlling the diagnosed obstructive sleep 
apnea. Certain medications which increase respiratory 
drive help some patients.  
  
3. Continuous positive airway pressure appliance 
(CPAP)  
Continuous positive airway pressure is the gold standard 
in treatment. CPAP treats patient by pumping room air 
under pressure through a sealed face mask or a nose 
mask through the upper airway to lung,
21
 however the 
treatment is associated with poor patient compliance 
due to lack of portability, pump noise, dryness of the 
airway passage, and mask discomfort.
22-24
 
CPAP is administered at bedtime through a nasal or 
facial mask held in place by velcro straps around the 
patient’s head. The mask is connected by a tube to a 
small air compressor. The CPAP machine sends air under 
pressure through the tube into the mask, where it 
imparts positive pressure to the upper airway. This 
essentially “splints” the upper airway open and keeps it 
from collapsing in the deeper stages of Rapid eye 
movement sleep. The pressure acts much in the same 
way as a splint, holding the airway open. 
 
4. Surgical correction 
Uvulopalatopharyngoplasty, partial tongue resection 
tracheostomy, lingual plasty, genioglossal advancement 
with hyoid myotomy and suspension nasal septal 
surgery hyoid bone suspension, and mandibular 
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 tracheostomy, lingual plasty, genioglossal advancement 
with hyoid myotomy and suspension nasal septal 
surgery hyoid bone suspension, and mandibular 
advancement osteotomy are the various surgical 
modalities suggested for obstructive sleep apnea.
19
 
In nasal, septal and adenoid surgery weak or 
malpositioned cartilages around the nostrils, droopy 
nasal tip or excessively narrow nostrils, nasal septal 
deviation and enlarged adenoids are all indicated for 
surgical interventions. 
Tonsillectomy allows the removal of redundant tissue 
and hence increases the caliber of the throat thereby 
reducing blockage to breathing. Genioglossus tongue 
advancement procedure produces a larger space 
between the back of the tongue and the throat thereby 
creating a wider airway. Uvulopalatopharyngoplasty 
(UPPP) involves the removal of part of the soft palate, 
uvula and redundant peripharyngeal tissues, sometimes 
including the tonsils. Laser-assisted uvulopalatoplasty 
like UPPP may decrease or eliminate snoring but not 
eliminate sleep apnea itself.  Maxillomandibular 
advancement or double jaw advancement is a procedure 
where the upper and lower jaws are surgically moved 
forward. Radiofrequency tissue volume reduction 
(RFTVR) is a surgical method which uses radiofrequency 
heating to create targeted coagulative submucosal 
lesions resulting in shrinkage of the inner tissues leaving 
the outer tissues intact. 
Hyoid suspension is a procedure which was developed 
specifically for the treatment of OSA. The operation 
advances the tongue base and epiglottis forward, 
thereby opening the breathingpassage at this level. 
 In Tracheostomy any area of blockage to breathing, 
from the nose to the voice-box, is bypassed by a hole 
placed into the windpipe. 
 
5. Oral appliance therapy 
 
They can be divided into three general groups: soft 
palate lifters (SPL), tongue retaining devices (TRD), and 
mandibular advancement appliances (MAA). The first 
category is virtually nolonger in use today. The second 
category is used very seldom, mainly if there are dental 
reasons precluding the construction of MAA. The last 
category (MAA) is by farther most common type of 
dental appliance in use today. It protrudes the mandible 
forward, thus preventing or minimizing upper airway 
collapse during sleep.
25 -29
 
 
Mechanism of action   
                                                                                                                                                     
Oral appliances are worn only during sleep and work to 
enlarge  the  airway  by  moving  the  tongue  or  the 
mandible  forward. 
 
Indications of oral appliance therapy    
                                                                                            
Given by American Academy of sleep medicine:
2 
( i) Oral 
appliances are indicated for use in patients with primary 
 
 with moderate to severe OSA should have an initial trial 
of nasal CPAP because greater effectiveness has been 
snoring or mild OSA who do not respond or are not 
appropriate candidates for treatment with behavioral 
measures such as weight  loss or change in sleep 
position ; (ii) Patients with moderate to severe OSA 
should have an initial trial of nasal CPAP because greater 
effectiveness has been shown with this intervention than 
with the use of oral appliances; (iii) Oral appliances are 
indicated for patients with moderate to severe OSA who 
are intolerant of, or refuse treatment with, nasal CPAP. 
Oral appliances are also indicated for patients who 
refuse or who are not candidates for tonsillectomy and 
adenoidectomy, cranial facial operations or 
tracheostomy. 
 
Contraindications   
                                                                                                                  
Severe periodontal disease, Existing TMJ disorders, 
Painful masseter muscles, Incomplete dentition which 
compromises retention of the appliance, atrophic 
edentulous ridges as evidenced by poor denture 
retention, severe hypoxemia, severe OSA,  growing 
children, protrusive range of mandible < 7 mm, mouth 
opening restricted to 30 mm or less, unmotivated 
patients, central sleep apnea. 
 
Mandibular advancement devices 
                                                                                                            
As mentioned earlier the first use of mandibular 
advancement devices was suggested by Pierre Robin in 
1903.
3
 It protrudes the mandible forward, thus 
preventing or minimizing upper airway collapse during 
sleep. These devices can be either fixed (i e, the 
protrusion distance cannot be changed), or variable (i e, 
protrusion can be increased or decreased). The final 
protrusion distance represents a delicate balance 
between side effects and efficacy. It has been shown by 
various studies that mandibular advancement devices 
significantly reduce AHI 
30-34
. 
 
 
Currently available appliances 
14 
 
First generation 
 
They are one piece appliance with no ability to advance 
the mandible incrementally. 
Second generation  
These appliances are principally two piece in design and 
offer the potential for incremental advancement. 
Third  generation                                                                                                                       
They not only permit incremental advancement, but also 
lateral movement of mandible. 
Fabrication technique     
                                                                                                                  
The mandibular advancement devices require good 
retention, sufficient protrusion to maintain airway, 
minimal vertical opening and full occlusal coverage. With 
either fixed or adjustable device, the initial position of 
mandible is generally 70 to 75%. The interocclusal 
records are made with patient protruded to 70 to 75% of 
the maximum protrusive movement and the device is 
fabricated. Single position stock devices (Therasnore) are 
fabricated in the form of two rigid plastic shells in the 
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 the maximum protrusive movement and the device is 
fabricated. Single position stock devices (Therasnore) are 
fabricated in the form of two rigid plastic shells in the 
shape of impression trays joined into a single unit. 
Retention is obtained from the thermoplastic fill 
material. Adjustable mandibular advancement devices 
(Quinsknight, P M positioner) are plastic impression trays 
filled with thermoplastic material for fitting to the 
patient and a mechanism for adjusting the mandible.  
 
Titration of oral appliances 
                                                                                                                  
It is a method of slowly moving the mandible anteriorly 
or posteriorly using adjustable mechanisms until 
symptoms are relieved with minimal possible protrusive 
position. Recall is necessary at 2 weeks, 1 month and 
every 6 months interval. 
Various studies have proven that mandibular 
advancement devices are an effective solution for 
significant number of patients with mild to moderate 
obstructive sleep apnea.
 35-36 
 
Tongue retaining devices 
                                                                                                       
Cartwright and Samelson described the tongue retaining 
device in 1982
37
. They are excellent devices for 
edentulous patients and patients with 
temperomandibular joint sensitivity. It is a one piece 
device made of non rigid vinyl material without 
thermoplastic material to adapt to teeth. It consists of 
Kelgauge template of various sizes. Patient is asked to 
protrude the tongue into the hollow bulb template of 
the appropriate size and interocclusal records are made. 
Appliance is fabricated with the help of these records. 
There are several advantages of Tongue retaining 
devices. They do not require retention from dentition, 
minimal adjustments are required and cause minimal 
sensitivity to teeth and temperomandibular joint.  
 
Side effects of oral appliance  
 
Patients may encounter any of the following: difficulty in 
going to sleep, salivation, chapped lips, dry throat, sore 
teeth, sensitive temporomandibular joints, and posterior 
teeth not occluding properly upon awakening. 
38-39
 
Difficulty to sleep can be resolved by suggesting that the 
patient go to sleep without the oral appliance; when his 
or her snoring becomes prominent to the patient's bed 
partner, the partner should awaken patient to insert the 
oral appliance. Sore teeth and sensitive 
temporomandibular joints should disappear within a 
couple of hours after the oral appliance is removed in 
the morning. If symptoms persist, the oral appliance 
requires immediate removal and possible adjustment by 
the clinician.  
 
Summary 
 
Oral appliances may increase upper airway size at 
multiple levels and this may be important in producing 
the last few years in terms of both quantity and quality. 
The role of these appliances in adolescents and children 
has yet to be evaluated in a comprehensive or 
their clinical effect. The literature describing oral 
appliance therapy for OSA has improved dramatically in 
the last few years in terms of both quantity and quality. 
The role of these appliances in adolescents and children 
has yet to be evaluated in a comprehensive or 
systematic way. Studies addressing these issues will 
advance the field of oral appliance therapy and improve 
the care being delivered to patients with OSA. 
 
 
References 
1. C. Dikens. Posthumous Papers of Pickwick                                                                                           
2. Waldhorn RE. Sleep Apnea Syndrome. Am Fam 
Physician.1985; 32:149-166. 
3. Robin P. Glossoptosis due to atresia and hypertrophy 
of the mandible. Am J Dis Child. 1934; 48: 541-547. 
4. Practice parameters for the treatment of snoring and 
obstructive sleep apnea with oral appliances. American 
Sleep Disorders Association. Sleep 1995; 18: 511-3.  
5. Mimi yow.  An overview of oral appliances and 
managing the airway in obstructive sleep apnea. Semin 
orthod  2009; 15: 88-93. 
6. Schwab RJ, Gupta KB, Gefter WB, Metzger LJ, Hoffman 
EA, Pack AI. Upper airway soft tissue anatomy in normal 
and patients with sleep disordered breathing: 
Significance of the lateral pharyngeal walls. Am J Respir 
Crit Care Med 1995; 152: 1673-89. 
7. Brown LK. Sleep apnea syndromes overview and 
diagnostic approach: Mt. Sinai J Med 1994; 61: 99-112.   
8. Chaudhary BA, Smith JK. Obstuctive sleep apnea 
syndrome. J Med Assoc Ga 1991; 80: 541-545.  
9. Goodday RH. Nasal respiration, nasal airway 
resistance, and obstructive sleep apnea syndrome. Oral 
Maxillofac Surg Clin North Am 1997; 9: 167-77. 
10. Remmers JE, DeGroot WJ, Sauerland EK, Anch AM. 
Pathogenesis of upper airway occlusion during sleep. J 
Appl Physiol 1978; 44: 931-8. 
11. Strobel RJ, Rosen RC. Obesity and weight loss in 
obstructive sleep apnea: a critical review. Sleep 1996; 19 
:104-15. 
12. Shintani T, Aaskura K, Kataura A. The effect of 
adenoidectomy in children With OSA. Int J Pediatr 
Otolaryngol 1998; 44: 51-58. 
13. Chan J, Edman JC, Koltai PJ. Obstuctive sleep apnea 
in children. Am Fam Phys 2004; 69: 1147-1154. 
14. Johal A. A review of the use of mandibular 
advancement appliances in sleep disordered Breathing. 
Dent Update 2008; 35:230-235. 
15. Bacon WH, Kreiger J, Turlot JC, Stierle JL. Craniofacial 
characteristics in patients with obstructive sleep apnea 
syndrome. Cleft Palate J 1988; 25:374-8.   
16. Imes NK, Orr WC, Smith RO, Rogers RM. 
Retrognathia and sleep. JAMA 1977;237:1596-7. 
17. Jamieson A, Guilleminault C, Partinen M, Quera-Salva 
MA.Obstructive sleep apnea patients have 
craniomandibular abnormalities. Sleep 1986; 9:469-77. 
18. Torrne LPM. The long face syndrome and the 
impairement of nasopharyngeal airway. Angle Orthod 
1990; 60: 167-176. 
 
 
   IJCDS • NOVEMBER, 2010 • 1(1) © 2010  Int. Journal of Clinical Dental Science 
  
36 
 19. Ivanhoe JR, Attanasio R . Sleep disorders and oral 
devices. Dent Clin North Am.  2001; 45:733–758. 
20. C Sunitha, S Aravind Kumar. Obstructive sleep apnea 
and its management. Indian J Dent Res. 2010 ; 21:119-
124.                                                                                                                                       
21. Ferguson KA, Ono T, Lowe AA, Keenan SP, Fleetham 
JA. A randomized crossover study of an oral appliance 
versus nasal continuous positive airway pressure in the 
treatment of mild-moderate sleep apnea. Chest 
1996;109: 1269-75. 
22. Dowey R III, Perkin RM, MacQuarrie J. Nasally applied 
continous positive airway pressure use in children with 
obstructive sleep apnea younger than 2 yrs of age. Chest 
2000;117:1608-1612. 
23. Hoffstein V, Viner S, Mateika S, Conway J. Treatment 
of obstructive sleep apnea with   nasal continuous 
positive airway pressure. Patient compliance, perception 
of benefits and side effect. Am Rev Respir Dis 1992;145: 
841-5.                                                                                                               
24.Kribbs NB, Pack AI, Kline LR, Smith PL, Schwartz AR, 
Schubert NM, et al. Objective measurements of patterns 
of nasal CPAP use by patients with obstructive sleep 
apnea. Am Rev Respir Dis 1993;147:887-95. 
25. Hoffstein V. Review of oral appliances for treatment 
of sleep-disordered breathing. Sleep Breath 2007;    
11:1–22. 
26. Ivanhoe JR. Treatment of upper airway sleep disorder 
patients with dental devices. Clinical Maxillofacial 
Prosthetics. Quintessence: Chicago; 2000; 215-31. 
27. Lyons MF, Cameron DA, Banham SW.  Snoring , sleep 
apnea and the role of oral appliances. Dent Update 
2001; 28:254-256. 
28. Ferguson KA. The role of oral appliance therapy in 
the treatment of obstructive sleep apnea. Clin Chest Med 
2003; 24:355–364. 
29. Cameron DA, Lyons MF, Fox DL, Banham SW. Pilot 
study of a flexible intra-oral appliance for the control of 
snoring. Br Dent J 1998; 85:304-7.  
30. Mohsenin N, Mostofi MT, Mohsenin V.  The role of 
oral appliances in treating obstructive sleep apnea. J Am 
Dent Assoc 2003; 34:442–449. 
31.Lindman R, Bondemark L.  A review of oral devices in 
the treatment of habitual snoring and obstructive sleep 
apnoea. Swed Dent J. 2001; 25:39–51. 
32. Schoem SR. Oral appliances for the treatment of 
snoring and obstructive sleep apnea. Otolaryngol Head 
Neck Surg. 2000; 122: 259–262. 
33. Bian H. Knowledge, opinions, and clinical experience 
of general practice dentists toward obstructive sleep 
apnea and oral appliances. Sleep Breath  2000; 8:85–90. 
34. Ferguson KA, Love LL, Ryan CF. Effects of a 
mandibular and tongue protrusion on upper airway size. 
Am J Respir Crit Care Med 1997;155: 1748-54. 
35.  Jauhar S et al. Ten year follow up of mandibular 
advancement devices for management of snoring and 
sleep apnea. J prosthet Dent 2008; 99: 314-321  
 
36. McGown AD, Marker H K, Battgel JM, Estrange PR, 
Grant HR , Spiro SG. Long term use of mandibular 
advancement splints for snoring and obstructive sleep 
apnea: a questionnaire survey. Eur Respir J 2001;17:462-6. 
37. Cartwright RD, Samelson CF.  The effects of a 
nonsurgical treatment for obstructive sleep apnea. The 
tongue-retaining device.  JAMA 1982; 248:705–709 
38.De Almeida FR, Lowe AA, Tsuiki S, Otsuka R, Wong M, 
Fastlicht S, Ryan CF. Long term compliance and side 
effects of oral appliances used for the treatment of 
snoring and obstructive sleep apnea syndrome. J Clin 
Sleep Med 2005;1:143–152 
39. Pantin CG, Hillman DR, Tennant M. Dental side effects 
of an oral device to treat snoring and obstructive sleep 
apnea. Sleep 1999; 22:237–240 
 
   IJCDS • NOVEMBER, 2010 • 1(1) © 2010  Int. Journal of Clinical Dental Science 
  
37 
